01Purpose and principlesWhat the treatment does and how it fits into care.
Endometrial ablation and hysterectomy are not equivalent stages of one automatic ladder. Ablation treats the endometrial surface while preserving the uterus; hysterectomy removes the bleeding organ. Both end uterine fertility in practical planning, but ablation can still be followed by a hazardous pregnancy. Selection follows symptom severity, prior treatment, cavity anatomy, pain mechanism, endometrial risk, comorbidity, preference and willingness to accept future retreatment.
Before procedural discussion, confirm that the diagnosis fits. Submucosal fibroids and polyps may be managed by hysteroscopic removal without global ablation. Large fibroids or substantial adenomyosis may reduce ablation success, particularly when pain is driven deep in myometrium. Persistent intermenstrual or postmenopausal bleeding requires direct endometrial evaluation. Revisit medical options, LNG-IUS suitability and fertility plans so the consent compares genuine alternatives rather than presenting surgery as inevitable.
Endometrial ablation uses thermal, radiofrequency or other device energy to destroy endometrium and superficial myometrium. Second-generation devices are inserted through the cervix and operate within specified cavity and wall parameters; some can be performed as day-case procedures. Preoperative assessment includes pregnancy exclusion, consented examination, ultrasound or hysteroscopy for cavity shape and fibroids, cervical and infection assessment and endometrial histology when bleeding risk requires it. Remove an intrauterine device before treatment.
Ablation outcomes should be described as reduction rather than guaranteed amenorrhoea. Bleeding may become lighter, stop or persist; dysmenorrhoea can improve or worsen depending on adenomyosis and outflow scarring. Complications include pain, cervical injury, uterine perforation, haemorrhage, infection, thermal damage to bowel or bladder, fluid complications with some techniques, haematometra and treatment failure. Subsequent scar can complicate assessment of new endometrial bleeding.
Pregnancy after ablation is uncommon but possible because ablation is not sterilisation. It has high risk of ectopic pregnancy, miscarriage, fetal growth problems, preterm birth, morbidly adherent placenta and uterine rupture. Patients who could conceive need effective contraception until menopause or sterilisation according to informed choice. Any positive pregnancy test or new bleeding and pain requires urgent assessment. Amenorrhoea after ablation is not proof of menopause.
Hysterectomy can be total, removing uterus and cervix, or subtotal, leaving cervix. It may be performed vaginally, laparoscopically, robotically where available or through an abdominal incision. Route is individualised to uterine size, descent, fibroids, adhesions, concurrent prolapse or adnexal procedure, obesity, previous surgery and surgeon expertise. Minimally invasive routes often shorten recovery but are not always technically safer for a particular patient.
Consent for hysterectomy covers certainty of no future uterine pregnancy, bleeding control, likely effect on pain, route and possible conversion, transfusion, infection, VTE, wound and vault complications, and injury to bladder, ureter, bowel, vessels or nerves. Discuss sexual function, pelvic floor and psychological meaning without assuming a uniformly negative or positive effect. If the cervix remains, future cervical screening generally continues; after total hysterectomy, screening depends on previous cervical disease and programme advice.
Ovaries and tubes require named decisions. Removing both ovaries before natural menopause causes immediate menopause and affects bone, cardiovascular, sexual and cognitive health; cancer-risk reduction may justify it in selected disease or inherited-risk contexts. Salpingectomy can be discussed separately, and ovarian conservation remains possible. The surgeon should not remove healthy ovaries merely because access is convenient unless the patient has consented to a clearly explained contingency.
Recovery and follow-up match route and complications. Early mobilisation, thromboprophylaxis, analgesia, bowel and bladder assessment and wound care reduce harm. Explain vaginal bleeding or discharge expected, activity and lifting limits, sex, driving and work based on the procedure rather than a universal timeline. Histology must be reviewed after hysterectomy, and new pain, bleeding or systemic symptoms after ablation need investigation even years later.
Key points
- Consider specialist procedural care when HMB is severe, medical treatment is declined or unsuccessful, or a structural lesion needs direct treatment; do not jump from one short tablet trial to definitive surgery.
- Endometrial ablation destroys the uterine lining to reduce bleeding while leaving the uterus in place; it is suitable only when future pregnancy is not desired and the cavity is appropriate.
- Ablation is not contraception. Use reliable contraception afterwards because pregnancy remains possible and carries increased ectopic, miscarriage, preterm and abnormal placentation risk.
- Before ablation, exclude pregnancy, assess the cavity and fibroids, address infection, investigate endometrial risk and obtain histology where indicated; device limits determine acceptable cavity dimensions and myometrial integrity.
- Ablation may cause amenorrhoea or reduced bleeding but does not guarantee either, and some patients need repeat treatment or later hysterectomy.
- Hysterectomy removes the uterus and is definitive for uterine bleeding; route may be vaginal, laparoscopic or abdominal according to uterine size, disease, previous surgery, expertise and other planned procedures.
- Discuss total versus subtotal hysterectomy, cervix implications, tubes and ovaries as separate decisions, expected recovery and effects on fertility and menopause.
- NICE advises a full discussion before hysterectomy covering sexual feelings, fertility, bladder function, complications, alternatives, psychological impact and expectations.
- Conserving normal ovaries avoids immediate surgical menopause, although menopause may occur earlier after hysterectomy; removing them may be appropriate for separate disease or cancer-risk indications.
- After either procedure, escalating pain, heavy bleeding, fever, offensive discharge, urinary problems, leg swelling, chest pain or breathlessness needs urgent review.
02Indications, selection and cautionsWho may benefit, who needs urgent treatment and important alternatives.
Completed fertility, benign assessed HMB, a suitable uterine cavity and acceptance of reliable contraception and retreatment risk supports ablation discussion.
Future pregnancy wishes, hyperplasia, suspicious bleeding, major cavity distortion or deep adenomyosis pain makes global endometrial destruction unsuitable or less effective.
Severe uterine symptoms persist despite acceptable alternatives, the patient wants definitive uterine treatment and understands irreversible fertility and operative risks.
New cyclical pain with little bleeding can reflect trapped blood behind intrauterine or cervical scarring and warrants imaging and specialist review.
Increasing pain, fever, ileus, urinary leakage, haematuria or renal dysfunction after hysterectomy may indicate bowel, bladder or ureter injury.
Unilateral leg swelling, pleuritic pain, unexplained tachycardia, hypoxia or breathlessness during recovery requires urgent VTE assessment.
03Assessment before treatmentTests and checks that guide safe selection.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Pregnancy and fertility assessmentFirst step - Why
- Confirm that pregnancy is absent and future pregnancy is not desired before ablation or hysterectomy.
- Interpretation and limitations
- A negative test does not replace a clear reproductive decision. Ablation still requires ongoing contraception because it is not sterilisation.
- 02
Cavity imaging and hysteroscopy - Why
- Define polyps, fibroids, uterine dimensions and distortion before selecting ablation or a focal procedure.
- Interpretation and limitations
- A focal lesion may be better removed directly. Each ablation device has anatomy and myometrial limits that must be met.
- 03
Endometrial histology - Why
- Exclude hyperplasia or malignancy when age, bleeding pattern or risk makes tissue diagnosis necessary.
- Interpretation and limitations
- Ablation obscures and scars endometrium and is not treatment for suspected cancer. Inadequate tissue requires resolution before proceeding.
- 04
Preoperative blood and anaesthetic assessment - Why
- Identify anaemia, transfusion risk, renal or cardiopulmonary disease, VTE risk and medicine adjustments.
- Interpretation and limitations
- Correct iron deficiency and plan thromboprophylaxis, blood availability and postoperative level of care according to procedure and comorbidity.
- 05
Cervical and ovarian risk review - Why
- Determine cervical screening implications and whether any separate adnexal procedure is indicated.
- Interpretation and limitations
- Total versus subtotal route affects the cervix; ovarian removal depends on pathology or cancer risk and explicit consent, not HMB alone.
- 06
Postoperative imaging and laboratory tests - Why
- Investigate suspected bleeding, haematometra, infection, obstruction, urinary or bowel injury.
- Interpretation and limitations
- Choose ultrasound, CT, blood count, renal profile and cultures from the presentation; normal early values cannot exclude evolving thermal or visceral injury.
04Treatment approachPreparation, options, escalation and aftercare.
01Procedure selectionCompare uterus-preserving and definitive optionsFirst stepDefinitiveHMB remains unacceptable after adequate medical and lesion-specific management or the patient declines those options.+
- 1Reconfirm diagnosis, pain mechanism, endometrial assessment, cavity anatomy, prior treatment and the patient’s fertility and bleeding priorities.
- 2DefinitiveCompare ablation’s shorter recovery and retreatment risk with hysterectomy’s definitive bleeding control and greater operative recovery and complication burden.
- 3Offer further medical, hysteroscopic, fibroid or no-procedure alternatives and document the patient’s material values before booking surgery.
02Ablation routeAssess cavity, histology and contraceptionThe patient requests ablation and does not want future pregnancy.+
- 1Exclude pregnancy, active infection and malignancy risk, assess endometrium and map cavity size, shape and fibroid distortion against device criteria.
- 2Explain expected bleeding reduction, pain, perforation, thermal injury, haematometra, failure and later diagnostic limitations, and agree post-procedure contraception.
- 3Perform with the selected anaesthetic and device protocol, document completeness and arrange urgent access and response review.
03Hysterectomy routeIndividualise route and organ decisionsDefinitiveDefinitive uterine treatment is chosen after shared consideration of alternatives.+
- 1Select vaginal, laparoscopic or abdominal route from anatomy, disease, previous surgery, concurrent procedures and local expertise, including possible conversion.
- 2Consent separately for cervix, tubes, ovaries, blood transfusion and unexpected findings and explain fertility, menopause, sexual, bladder and recovery implications.
- 3Optimise anaemia and comorbidity, provide thromboprophylaxis and enhanced recovery, and track operative histology and complications.
04Post-procedure symptomsDistinguish expected recovery from complicationPain, bleeding, discharge, urinary, bowel or cardiopulmonary symptoms occur after ablation or hysterectomy.+
- 1Assess physiology, severity and trajectory and examine abdomen, wounds and genital bleeding with consent rather than relying on elapsed postoperative days.
- 2EscalationEscalate heavy bleeding, fever, progressive pain, ileus, urinary change, leg swelling, chest pain or breathlessness to the operating service urgently.
- 3Use imaging and laboratory tests to identify haematometra, haemorrhage, infection, VTE or visceral injury and provide cause-specific treatment.
05Complications, monitoring and follow-upAdverse effects, response and longer-term review.
- After ablation track bleeding, cyclical pain, pregnancy risk and contraception; investigate new or recurrent bleeding rather than assuming the endometrium is inaccessible and benign.
- After hysterectomy monitor observations, haemoglobin, urine output, bowel function, wound, vaginal loss, pain control and VTE prevention according to route and recovery.
- Review all operative and endometrial histology to a documented outcome and communicate unexpected hyperplasia, malignancy or cervical disease urgently.
- Confirm cervical screening advice after total or subtotal hysterectomy and document whether cervix, tubes and ovaries were retained or removed.
- At follow-up reassess the original bleeding and pain goals, sexual and psychological wellbeing, bladder or bowel symptoms and any need for menopause care.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Ablation is neither sterilisation nor menopause
Ovulation can continue and conception remains possible, so amenorrhoea after endometrial destruction cannot be used as contraception or menopause diagnosis.
Pain mechanism predicts satisfaction
Surface bleeding may improve while deep adenomyosis or extrauterine endometriosis pain persists, making diagnostic clarity important before ablation.
Definitive for bleeding, not every symptom
Hysterectomy stops uterine bleeding but cannot guarantee resolution of pelvic-floor, bladder, bowel, neuropathic or extrauterine pain.
Cervix changes surveillance
Subtotal hysterectomy leaves cervical tissue and usually ongoing screening eligibility, while total removal still requires programme-specific review of previous abnormalities.
Conserved ovaries still age
Ovarian retention prevents immediate surgical menopause, although ovarian function may decline earlier than it would without hysterectomy.
07Common pitfallsFrequent interpretation and management errors.
- 01
Offering ablation before resolving future pregnancy wishes, pregnancy status and endometrial cancer risk.
- 02
Telling a patient that ablation is contraception or guarantees amenorrhoea.
- 03
Using global ablation for a focal submucosal fibroid that needs hysteroscopic removal and histology.
- 04
Presenting hysterectomy as the inevitable next step after one poorly tolerated medicine without discussing alternatives.
- 05
Including bilateral oophorectomy in benign HMB consent without a separate indication and surgical-menopause discussion.
- 06
Dismissing progressive postoperative pain or urinary symptoms because the operation note described no complication.